OBJECTIVES: Genetic disorders are the main causes of many other diseases. Integrating genetic data into Electronic Health Records (EHRs) can facilitate the management of genetic information and care of patients in clinical practices. The aim of this study was to identify the main requirements for integrating genetic data into the EHR system from the medical geneticists' perspectives. METHODS: The research was completed in 2018 and consisted of two phases. In the first phase, the main requirements for integrating genetic data into the EHR system were identified by reviewing the literature. In the second phase, a 5-point Likert scale questionnaire was developed based on the literature review and the results derived from the first phase. Then, the Delphi method was applied to reach a consensus about the integration requirements. RESULTS: The findings of the first phase showed that data elements, including patients' and healthcare providers' personal data, clinical and genetic data, technical infrastructure, security issues and functional requirements, should be taken into account before data integration. In the second phase, a consensus was reached for most of the items (mean ≥3.75). The items with a mean value of less than 2.5 did not achieve a consensus and were removed from the final list. CONCLUSIONS: The integration of genetic data into the EHRs can provide a ground for increasing accuracy and precision in the diagnosis and treatment of genetic disorders. Such integration requires adequate investments to identify users' requirements as well as technical and non-technical issues.
Consensus ; Delivery of Health Care ; Diagnosis ; Electronic Health Records ; Genetics ; Humans ; Investments ; Medical Informatics ; Methods

Objective To investigate the healing effects of two herbal preparations. Methods For this purpose, 106 wistar rats were divided into 9 groups including a control, eucerine, phenytoin, Urtica dioica (U. dioica) (2%), U. dioica (5%), Sambucus ebulus (S. ebulus) (2%), S. ebulus (5%), combination (2%), and combination (5%) groups. The control group remained untreated, the eucerin and phenytoin groups were considered as the negative and positive controls respectively, and the remaining groups received different concentrations of the ointments. Full thickness wounds were made. The healing process of the wounds was investigated on day 7, 14 and 21 of the experiment. Several factors including the number of fibroblasts, new vessel formation (angiogenesis), thickness of the granulomatous tissues (GT), and the overlying epithelium were analyzed. Results Among the studied groups, all of the treatment groups were significantly different from the control, eucerin, and phenytoin groups in a positive manner with regard to all studied factors (P ≤ 0.05). However, the best results were observed with the S. ebulus (2%) and the combination 2% groups (P ≤ 0.05). Conclusions Topical ointments prepared from the extracts of U. dioica and S. ebulus and their combination possess strong wound healing properties. It is postulated that a synergistic effect may exist between the two extracts since the combination 2% showed better results than the sole extracts.